Effect of SARS-CoV-2 Infection on Incident Diabetes by Viral Variant: Findings From the National COVID Cohort Collaborative (N3C)
Incident diabetes risk after COVID-19 was similar across different SARS-CoV-2 variants. However, there was greater latency in diabetes onset in the Omicron variant era.
Authors
- Carolyn T. Bramante (ORCID: https://orcid.org/0000-0001-5858-2080)
- Talia D. Wiggen (ORCID: https://orcid.org/0000-0002-5234-3238)
- Jane E.B. Reusch (ORCID: https://orcid.org/0000-0001-8620-1003)
- John B. Buse (ORCID: https://orcid.org/0000-0002-9723-3876)
- Til Stürmer (ORCID: https://orcid.org/0000-0002-9204-7177)
- Steve Johnson (ORCID: https://orcid.org/0000-0002-2983-6384)
- Margeret Hall (ORCID: https://orcid.org/0000-0003-1049-3040)
- Hsin‐Chieh Yeh (ORCID: https://orcid.org/0000-0002-5738-0652)
- Jared D. Huling (ORCID: https://orcid.org/0000-0003-0670-4845)
- Kenneth J. Wilkins (ORCID: https://orcid.org/0000-0003-0531-7165)
- Rachel Wong (ORCID: https://orcid.org/0000-0003-3108-7324)
- Lindsey E. Turner (ORCID: https://orcid.org/0000-0003-2839-901X)
Institutions
- University of North Carolina at Chapel Hill (US)
- National Institutes of Health (US)
- University of Minnesota (US)
- Johns Hopkins University (US)
- Emory University (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Office of the Director (US)
- University of Minnesota Medical Center (US)
- University of Colorado Anschutz Medical Campus (US)
- Stony Brook University (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2024-08-29
- DOI
- https://doi.org/10.2337/dc24-1003
- Citations
- 3
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases